The combination of genomic and proteomic data can reveal novel insights relating to important biological processes in cancer. The acquisition of proteomic data from 979 cancer cell lines, derived from over 7000 data independent acquisition mass spectrometry runs generated at ProCan, Sydney, is presented. Proteomic data is integrated with existing multi-omic datasets available via the COSMIC project, and proteogenomic relationships are characterised.